Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Price:
481.23
USD
-3.23%
Market Closed
Market Cap:
$11B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
US |
|
C
|
Canadian Natural Resources Ltd
XMUN:CRC
|
CA |
|
3i Group PLC
LSE:III
|
UK |
|
Resmed Inc
NYSE:RMD
|
US |
|
Ascendas Real Estate Investment Trust
SGX:A17U
|
SG |
|
Dana Brata Luhur Tbk PT
IDX:TEBE
|
ID |
|
Spotify Technology SA
NYSE:SPOT
|
LU |
|
United Airlines Holdings Inc
NASDAQ:UAL
|
US |
|
Teleperformance SE
PAR:TEP
|
FR |
Wall St Price Targets
MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc
Wall Street analysts forecast MDGL stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for MDGL is 691.65 USD with a low forecast of 555.5 USD and a high forecast of 1 012.2 USD.
Lowest Forecast
Price Target
555.5
USD
15% Upside
Average Forecast
Price Target
691.65
USD
44% Upside
Highest Forecast
Price Target
1 012.2
USD
110% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MDGL's stock price target?
Price Target
691.65
USD
691.65
USD
According to Wall Street analysts, the average 1-year price target for MDGL is 691.65 USD with a low forecast of 555.5 USD and a high forecast of 1 012.2 USD.
What is the Revenue forecast for Madrigal Pharmaceuticals Inc?
Projected CAGR
27%
27%
Over the last 13 years, the compound annual growth rate for Revenue has been 102%. The projected CAGR for the next 8 years is 27%.
